KIAA1549 and diffuse astrocytoma: For example, in one of the positive studies, the KIAA1549:BRAF fusion was associated with better clinical outcome in the large cohort by Hawkins et al. of pediatric low-grade astrocytomas including PAs, PMAs, and diffuse astrocytomas (32).